Tevogen Bio Holdings Inc.
LGST
Revenue
0.00
0.000.00%
-Assets
3.31M
▼-53.15k▼-1.58%
3 Months ChangeLiabilities
10.94M
▲1.78M▲19.40%
3 Months ChangeFree Cash Flow
-2.31M
▼-2.31M-∞%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-06-21
Form 8-K
ID: 0001493152-24-024727
2024-06-11
Form 8-K
ID: 0001493152-24-023483
2024-05-28
Form 10-Q
ID: 0001493152-24-021650
2024-05-16
Form 8-K
ID: 0001493152-24-020275
2024-05-02
Form 8-K
ID: 0001493152-24-017597
2024-04-26
Form 8-K
ID: 0001493152-24-016060
2024-04-02
Form 8-K
ID: 0001493152-24-012650
2024-03-21
Form 8-K
ID: 0001493152-24-010806
2024-02-21
Form 8-K
ID: 0001493152-24-007408
2024-02-14
Form 8-K
ID: 0001493152-24-006751